These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 540061

  • 21. Complete amino acid sequence of murine beta 2-microglobulin: structural evidence for strain-related polymorphism.
    Gates FT, Coligan JE, Kindt TJ.
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):554-8. PubMed ID: 6165997
    [Abstract] [Full Text] [Related]

  • 22. Central antihypertensive effects of inhibitors of the renin-angiotensin system in rats.
    Sweet CS, Columbo JM, Gaul SL.
    Am J Physiol; 1976 Dec; 231(6):1794-9. PubMed ID: 188343
    [Abstract] [Full Text] [Related]

  • 23. Utilisation of the isobole methodology to study dietary peptide-drug and peptide-peptide interactive effects on dipeptidyl peptidase IV (DPP-IV) inhibition.
    Nongonierma AB, FitzGerald RJ.
    Food Funct; 2015 Jan; 6(1):313-20. PubMed ID: 25477187
    [Abstract] [Full Text] [Related]

  • 24. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D, Santos RA, Etelvino GM, Xavier CH, de Almeida Santos J, Mendes EP, Machado LT, Prezoto BC, Dive V, de Camargo AC.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [Abstract] [Full Text] [Related]

  • 25. Metabolism of labetalol by animals and man.
    Martin LE, Hopkins R, Bland R.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [Abstract] [Full Text] [Related]

  • 26. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG, Donohue JA, Duket LH.
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [Abstract] [Full Text] [Related]

  • 27. [Peptide inhibitors of the renin-angiotensin system. 2. Polymer-bound tri-, penta- and nonapeptide inhibitors of angiotensin converting enzyme].
    Reissmann S, Filatova MP, Krit NA, Feist H.
    Pharmazie; 1992 Jul; 47(7):498-501. PubMed ID: 1381510
    [Abstract] [Full Text] [Related]

  • 28. Using bradykinin-potentiating peptide structures to develop new antihypertensive drugs.
    Fernandez JH, Neshich G, Camargo AC.
    Genet Mol Res; 2004 Dec 30; 3(4):554-63. PubMed ID: 15688321
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterization of urinary metabolites from four synthetic bradykinin potentiating peptides (BPPs) in mice.
    Silva CA, Ianzer DA, Portaro FC, Konno K, Faria M, Fernandes BL, Camargo AC.
    Toxicon; 2008 Sep 01; 52(3):501-7. PubMed ID: 18652839
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of D-amino acid substituents on degradation of LHRH analogues by proximal tubule.
    Flouret G, Majewski T, Peterson DR, Kenny AJ, Carone FA.
    Am J Physiol; 1987 Mar 01; 252(3 Pt 1):E320-6. PubMed ID: 3548429
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Substrate specificity of cucumisin on synthetic peptides.
    Yonezawa H, Kaizuka H, Uchikoba T, Arima K, Kaneda M.
    Biosci Biotechnol Biochem; 2000 Oct 01; 64(10):2104-8. PubMed ID: 11129582
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.